BHCM
VSTM icon

Brevan Howard Capital Management’s Verastem VSTM Stock Holding History

Brevan Howard Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
72,383
+21,225
+41% +$103K ﹤0.01% 1756
2026
Q1 		$271K Buy
51,158
+25,986
+103% +$160K ﹤0.01% 1690
2025
Q4 		$194K Buy
+25,172
New +$224K ﹤0.01% 1591
2024
Q2 		– Sell
-24,102
Closed -$285K – 1421
2024
Q1 		$285K Buy
+24,102
New +$278K ﹤0.01% 678

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Brevan Howard Capital Management's VSTM Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Verastem (VSTM) stake by 41% in Q2 2026, buying an estimated $103K and bringing the position to 72,383 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #1756.

Brevan Howard Capital Management first reported a position in VSTM in Q1 2024 and has held it in 4 quarters since. The position peaked at $285K in Q1 2024. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Brevan Howard Capital Management held 72,383 shares of Verastem worth $276K as of Q2 2026.
  • Brevan Howard Capital Management bought 21,225 Verastem shares in Q2 2026, an estimated $103K.
  • Verastem made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1756 holding.
  • Brevan Howard Capital Management first reported a position in Verastem in Q1 2024 and has held it in 4 quarters since.
  • Brevan Howard Capital Management's Verastem position peaked at $285K in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.